UB Paderborn / Katalog / Suche / in CDI

Potent, Structurally Constrained Agonists and Competitive Antagonists of Corticotropin-Releasing Factor

Proceedings of the National Academy of Sciences - PNAS, 1995-11, Vol.92 (23), p.10575-10579

1995

Volltextzugriff (PDF)

Constrained Corticotropin Releasing Factor Antagonists (Astressin Analogues) with Long Duration of Action in the Rat

Journal of medicinal chemistry, 1999-08, Vol.42 (16), p.3175-3182

1999

Volltextzugriff (PDF)

Constrained Corticotropin-Releasing Factor Antagonists with i-(i + 3) Glu−Lys Bridges

Journal of medicinal chemistry, 1997-10, Vol.40 (22), p.3651-3658

1997

Volltextzugriff (PDF)

Design of Monocyclic (1−3) and Dicyclic (1−3/4−10) Gonadotropin Releasing Hormone (GnRH) Antagonists

Journal of medicinal chemistry, 2000-03, Vol.43 (5), p.797-806

2000

Volltextzugriff (PDF)

Design of Potent Dicyclic (4−10/5−8) Gonadotropin Releasing Hormone (GnRH) Antagonists

Journal of medicinal chemistry, 2000-03, Vol.43 (5), p.784-796

2000

Volltextzugriff (PDF)

Constrained Corticotropin-Releasing Factor (CRF) Agonists and Antagonists with i−(i+3) Glu-Xaa-dXbb-Lys Bridges

Journal of medicinal chemistry, 1998-12, Vol.41 (25), p.5002-5011

1998

Volltextzugriff (PDF)

Conformationally Restricted Competitive Antagonists of Human/Rat Corticotropin-Releasing Factor

Journal of medicinal chemistry, 1994-05, Vol.37 (10), p.1450-1459

1994

Volltextzugriff (PDF)

Dose relationship between GnRH antagonists and pituitary suppression

Human reproduction (Oxford), 1996-11, Vol.11 (suppl-3), p.133-147

1996

Volltextzugriff (PDF)

Ligand requirements of the human corticotropin-releasing factor-binding protein

Endocrinology (Philadelphia), 1995-03, Vol.136 (3), p.1097-1102

1995

Volltextzugriff (PDF)

Minimal-Size, Constrained Corticotropin-Releasing Factor Agonists with i−(i+3) Glu−Lys and Lys−Glu Bridges

Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2614-2620

1998

Volltextzugriff (PDF)

Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization

Journal of comparative neurology (1911), 1996-01, Vol.364 (2), p.324-339

1996

Volltextzugriff (PDF)

Ligand requirements of the human corticotropin-releasing factor-binding protein

Endocrinology (Philadelphia), 1995-03, Vol.136 (3), p.1097-1102

1995

Volltextzugriff (PDF)

Dose relationship between GnRH antagonists and pituitary suppression: GnRH analogues and reproductive medicine

Human reproduction (Oxford), 1996, Vol.11, p.133-147

1996

Volltextzugriff (PDF)

Validation and clinical application of a multiplex high performance liquid chromatography – tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020-11, Vol.1157, p.122160, Article 122160

2020

Volltextzugriff (PDF)

A new split-based hybrid metaheuristic for the reconfigurable transfer line balancing problem

International journal of production research, 2021-02, Vol.59 (4), p.1127-1144

2021

Volltextzugriff (PDF)

Food Peptidomics: Large scale analysis of small bioactive peptides — A pilot study

Journal of proteomics, 2013-08, Vol.88, p.83-91

2013

Volltextzugriff (PDF)

Fine-grained simulation optimization for the design and operations of a multi-activity clinic

Flexible services and manufacturing journal, 2020-09, Vol.32 (3), p.599-628

2020

Volltextzugriff (PDF)

A data-driven approach to include availability of ICU beds in the planning of the operating room

Omega (Oxford), 2022-06, Vol.109, p.102608, Article 102608

2022

Volltextzugriff (PDF)

Corrigendum to “Validation and clinical application of a multiplex high performance liquid chromatography – Tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections” [J. Chromatogr. B 1157 (2020) 122160]

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022-11, Vol.1211, p.123497-123497, Article 123497

2022

Volltextzugriff (PDF)

Imatinib metabolite profiling in parallel to imatinib quantification in plasma of treated patients using liquid chromatography-mass spectrometry

Journal of mass spectrometry., 2008-06, Vol.43 (6), p.736-752

2008

Volltextzugriff (PDF)

Pathophysiological aspects of renal stone formation and stone types

Notulae scientia biologicae, 2023-03, Vol.15 (1), p.11462

2023

Volltextzugriff (PDF)

Synthesis and Physico-chemical Characterization of Solid Solution (1-x)CCTO−xPbTiO3

Asian journal of chemistry, 2021-06, Vol.33 (6), p.1208-1214

2021

Volltextzugriff (PDF)

Online Optimization of Radiation Therapy Patient Scheduling

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S543-S543

2012

Volltextzugriff (PDF)

Intérêt de la rééducation fonctionnelle dans la capsulite rétractile chez les diabétiques

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A295

2021

Volltextzugriff (PDF)

Le syndrome du canal carpien et le diabète

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A169

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Potent, Structurally Constrained Agonists and Competitive Antagonists of Corticotropin-Releasing Factor

Constrained Corticotropin Releasing Factor Antagonists (Astressin Analogues) with Long Duration of Action in the Rat

Constrained Corticotropin-Releasing Factor Antagonists with i-(i + 3) Glu−Lys Bridges

Design of Monocyclic (1−3) and Dicyclic (1−3/4−10) Gonadotropin Releasing Hormone (GnRH) Antagonists

Design of Potent Dicyclic (4−10/5−8) Gonadotropin Releasing Hormone (GnRH) Antagonists

Constrained Corticotropin-Releasing Factor (CRF) Agonists and Antagonists with i−(i+3) Glu-Xaa-dXbb-Lys Bridges

Conformationally Restricted Competitive Antagonists of Human/Rat Corticotropin-Releasing Factor

Dose relationship between GnRH antagonists and pituitary suppression

Ligand requirements of the human corticotropin-releasing factor-binding protein

Minimal-Size, Constrained Corticotropin-Releasing Factor Agonists with i−(i+3) Glu−Lys and Lys−Glu Bridges

Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization

Ligand requirements of the human corticotropin-releasing factor-binding protein

Dose relationship between GnRH antagonists and pituitary suppression: GnRH analogues and reproductive medicine

Validation and clinical application of a multiplex high performance liquid chromatography – tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections

A new split-based hybrid metaheuristic for the reconfigurable transfer line balancing problem

Food Peptidomics: Large scale analysis of small bioactive peptides — A pilot study

Fine-grained simulation optimization for the design and operations of a multi-activity clinic

A data-driven approach to include availability of ICU beds in the planning of the operating room

Corrigendum to “Validation and clinical application of a multiplex high performance liquid chromatography – Tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections” [J. Chromatogr. B 1157 (2020) 122160]

Imatinib metabolite profiling in parallel to imatinib quantification in plasma of treated patients using liquid chromatography-mass spectrometry

Pathophysiological aspects of renal stone formation and stone types

Synthesis and Physico-chemical Characterization of Solid Solution (1-x)CCTO−xPbTiO3

Online Optimization of Radiation Therapy Patient Scheduling

Intérêt de la rééducation fonctionnelle dans la capsulite rétractile chez les diabétiques

Le syndrome du canal carpien et le diabète

Suchergebnisse filtern